Stay updated on Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors
Sign up to get notified when there's something new on the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page.

Latest updates to the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page
- Check4 days agoChange DetectedThe page shows Revision: v3.6.2, replacing the previous Revision: v3.6.0. This indicates a minor version update to the page's underlying software or content.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded metadata and help/navigation items such as 'Last verified', 'Last known status was', 'How to Read a Study Record', 'Common Questions', 'How to Join a Study', and a 'Revision: v3.6.0' marker; removed older labels and revision indicators including 'Verified', 'Last known status was:', 'Intervention / Treatment', and 'Revision: v3.5.5'.SummaryDifference0.6%

- Check25 days agoChange DetectedThe page's revision metadata was updated to v3.5.5, adding a 'Last known status' section with sponsor, date, and verification details.SummaryDifference0.2%

- Check47 days agoChange DetectedRevision tag on the page updated from v3.5.3 to v3.5.4, signaling a minor site update. This reflects a backend or formatting change without altering the study content.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page revision label was updated from v3.5.2 to v3.5.3, indicating a site build/version bump without any change to the clinical study content shown.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No visible changes to page content or user-facing features.SummaryDifference0.0%

Stay in the know with updates to Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors
Enter your email address, and we'll notify you when there's something new on the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page.